The National Institutes of Health (NIH) has renewed its support of the Tennessee Center for AIDS Research (CFAR), a four-way partnership between Vanderbilt University Medical Center, Meharry Medical College, the Tennessee Department of Health and Nashville CARES.

VHVI’s cardiac surgery and heart failure teams recently celebrated a milestone — implanting the 500th adult patient with a ventricular assist device.

According to the U.S. Centers for Disease Control and Prevention, fewer than 1% of the population is truly allergic to penicillin. The rest were never allergic to begin with or have outgrown their allergy — an estimated 80% of people with penicillin allergy lose their sensitivity to the drug within 10 years.

Electronic health records and biobanks can be effectively combined to detect and study Mendelian diseases such as cystic fibrosis.

A new clinic opening at Vanderbilt University Medical Center will help doctors and patients choose the best drugs for their medical conditions based on the patients’ unique genetic makeup.

A multi-institutional consortium led by Vanderbilt-Ingram Cancer Center (VICC) is collecting data on cancer patients with COVID-19 as part of a rapid effort to understand the unique effects the coronavirus has on this vulnerable population.

Vanderbilt University Medical Center investigators have joined an international genetics effort to make advances as quickly as possible on understanding and treating COVID-19.